title: FDA eases restrictions on the glucose-lowering drug rosiglitazone.
authors.forename: Mike
authors.initials: M
authors.lastname: Mitka
mesh_terms: D016757:Death, Sudden, Cardiac / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000592:standards; D009203:Myocardial Infarction / Q000453:epidemiology; D010818:Practice Patterns, Physicians'; D012306:Risk; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone